Abstract
Thickening of the basement membrane zone (BMZ) is a characteristic feature of airway remodeling. The BMZ appears as three component layers: the laminas lucida, densa, and reticularis. The lamina reticularis of the BMZ is thickened in asthma, allergic rhinitis, eosinophil bronchitis and lung transplants. Collagen types I, III and V form heterogeneous fibers that account for the thickness of the BMZ. Proteoglycans are structural component of the BMZ responsible for many of its functions, in particular, trafficking of growth factors and cytokines between epithelial and mesenchymal cells. An important function of the BMZ is storage and regulation of fibroblast growth factor-2 (FGF-2). FGF-2 has been shown to be involved with normal growth and thickening of the BMZ. Treatment with corticosteroids reduces the width of the BMZ in asthmatics. The significance of BMZ thickening in airway function is not clear however, it may have a positive effect by physically protecting against airway narrowing and air trapping. Thickening of the BMZ may have a negative effect by influencing how the epithelial mesenchymal trophic unit functions. However at this point there are no studies showing abnormal trafficking of growth factors and cytokines due to thickening of the BMZ.
Keywords: Basement membrane zone, lamina reticularis, collagen, perlecan, fibroblast growth factor-2
Current Respiratory Medicine Reviews
Title: The Basement Membrane Zone in Asthma
Volume: 2 Issue: 3
Author(s): Michael J. Evans, Michelle V. Fanucchi and Charles G. Plopper
Affiliation:
Keywords: Basement membrane zone, lamina reticularis, collagen, perlecan, fibroblast growth factor-2
Abstract: Thickening of the basement membrane zone (BMZ) is a characteristic feature of airway remodeling. The BMZ appears as three component layers: the laminas lucida, densa, and reticularis. The lamina reticularis of the BMZ is thickened in asthma, allergic rhinitis, eosinophil bronchitis and lung transplants. Collagen types I, III and V form heterogeneous fibers that account for the thickness of the BMZ. Proteoglycans are structural component of the BMZ responsible for many of its functions, in particular, trafficking of growth factors and cytokines between epithelial and mesenchymal cells. An important function of the BMZ is storage and regulation of fibroblast growth factor-2 (FGF-2). FGF-2 has been shown to be involved with normal growth and thickening of the BMZ. Treatment with corticosteroids reduces the width of the BMZ in asthmatics. The significance of BMZ thickening in airway function is not clear however, it may have a positive effect by physically protecting against airway narrowing and air trapping. Thickening of the BMZ may have a negative effect by influencing how the epithelial mesenchymal trophic unit functions. However at this point there are no studies showing abnormal trafficking of growth factors and cytokines due to thickening of the BMZ.
Export Options
About this article
Cite this article as:
Evans J. Michael, Fanucchi V. Michelle and Plopper G. Charles, The Basement Membrane Zone in Asthma, Current Respiratory Medicine Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339806778018999
DOI https://dx.doi.org/10.2174/157339806778018999 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endotoxin, TLR4 Signaling and Vascular Inflammation: Potential Therapeutic Targets in Cardiovascular Disease
Current Pharmaceutical Design Bilayer Tablet Based Chronotherapeutics in the Management of Nocturnal Asthma: An Overview
Recent Patents on Drug Delivery & Formulation Subject Index Volume 2
Current Pediatric Reviews Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Current Drug Targets Chlorination Products: Emerging Links with Allergic Diseases
Current Medicinal Chemistry Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets Inhibition of Inflammation by a p38 MAP Kinase Targeted Cell Permeable Peptide
Medicinal Chemistry A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis
Current Medicinal Chemistry Role of Biotransformation in Conceptal Toxicity of Drugs and Other Chemicals
Current Pharmaceutical Design Impacts of Particulate Air Pollution on Asthma: Current Understanding and Future Perspectives
Recent Patents on Inflammation & Allergy Drug Discovery Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer’s Disease
Current Medicinal Chemistry ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies
Current Pharmaceutical Design Protocatechuic Acid Alkyl Esters: Hydrophobicity As a Determinant Factor for Inhibition of NADPH Oxidase
Current Medicinal Chemistry Heat Shock Paradox and a New Role of Heat Shock Proteins and their Receptors as Anti-Inflammation Targets
Inflammation & Allergy - Drug Targets (Discontinued) A Possible Role for Interleukin 37 in the Pathogenesis of Behcet's Disease
Current Molecular Medicine The Emerging Role of Unmetabolized Folic Acid in Human Diseases: Myth or Reality?
Current Drug Metabolism Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)
Current Pharmaceutical Design A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer
Medicinal Chemistry Globalization of Clinical Trials – Where are We Heading?
Current Clinical Pharmacology Extracts of Bacopa monnieri (L) Pennell Down-Regulate the Expression of Leukotriene C<sub>4</sub> Synthase mRNA in HL-60 Cells and Suppress OVAInduced Inflammation in BALB/c Mice
Current Bioactive Compounds